Picture Sino Biological Symposium Antibody Engineering Leipzig 650x100px
Organisation › Details

Ysios Capital Partners SGECR S.A.

Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early- and mid-stage, highly innovative life science companies bringing life-changing treatments to patients, with a focus on indications with high unmet need. Our diverse international team in San Sebastián and Barcelona is driven by science, with the ambition to transform capital into medical breakthroughs. Ysios Capital was founded in 2008 and has over $450 million in assets under management through its three funds. *


Name: Ysios Capital Partners



Address: travessera de gràcia, 11 floor 8th 08021 Barcelona, Catalonia, Spain
Telephone: +34-93-5173545
General contact:


Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early- and mid-stage human healthcare and life science companies with a special focus on pharmaceuticals, diagnostics and medical devices.

Founded in 2008, Ysios Capital has € 125 million in assets under management distributed over two funds. The second fund has a target size of € 100 million and will remain open to new investors until December 2015.

Industry: Venture capital, life sciences

Products/Services: Investment

Established: 2008

Employees: 11

The organisation submitted the information to [LSE] on 18 August 2015.

Period Start 2008-01-01 established
  Group Ysios Capital (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Casellas, Marc (SOM Biotech 202106– CFO before Ysios Capital Partners + Danone Group + PwC Consulting)
  Person 2 Jean-Mairet, Joël (Ysios Capital 201206)
Region Region Barcelona
  Country Spain (España)
  Street 11 Travessera de Gràcia
8th Floor
  City 08021 Barcelona
  Tel +34-93-517-3545
    Address record changed: 2021-04-28
Basic data Employees B: 11 to 50 (2015-08-18)
  Currency EUR
  Annual sales 450,000,000 (assets, managed (2022) 2022-03-04)
    * Document for »About Section«: Ysios Capital. (3/4/22). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Thomas Harth as Principal Thomas Harth". San Sebastián & Barcelona.
Record changed: 2024-05-07


Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

More documents for Ysios Capital (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top